Anti-VWCE/ URG11/ VWC1 functional antibody
Anti-VWCE/ URG11/ VWC1 functional antibody for cell culture, ELISA & in-vivo assay
Go to VWCE/VWCE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc) 
Product information
| Catalog No. | Product Name | Species Reactivity | 
|---|---|---|
| GM-Tg-hg-SE1369-Ab-1/ GM-Tg-hg-SE1369-Ab-2 | Anti-Human VWCE monoclonal antibody | Human | 
| GM-Tg-rg-SE1369-Ab-1/ GM-Tg-rg-SE1369-Ab-2 | Anti-Rat VWCE monoclonal antibody | Rat | 
| GM-Tg-mg-SE1369-Ab-1/ GM-Tg-mg-SE1369-Ab-2 | Anti-Mouse VWCE monoclonal antibody | Mouse | 
| GM-Tg-cynog-SE1369-Ab-1/ GM-Tg-cynog-SE1369-Ab-2 | Anti-Cynomolgus/ Rhesus macaque VWCE monoclonal antibody | Cynomolgus/ Rhesus macaque | 
| GM-Tg-felg-SE1369-Ab-1/ GM-Tg-felg-SE1369-Ab-2 | Anti-Feline VWCE monoclonal antibody | Feline | 
| GM-Tg-cang-SE1369-Ab-1/ GM-Tg-cang-SE1369-Ab-2 | Anti-Canine VWCE monoclonal antibody | Canine | 
| GM-Tg-bovg-SE1369-Ab-1/ GM-Tg-bovg-SE1369-Ab-2 | Anti-Bovine VWCE monoclonal antibody | Bovine | 
| GM-Tg-equg-SE1369-Ab-1/ GM-Tg-equg-SE1369-Ab-2 | Anti-Equine VWCE monoclonal antibody | Equine | 
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE1369-Ab-1/ GM-Tg-hg-SE1369-Ab-2; GM-Tg-rg-SE1369-Ab-1/ GM-Tg-rg-SE1369-Ab-2;  GM-Tg-mg-SE1369-Ab-1/ GM-Tg-mg-SE1369-Ab-2; GM-Tg-cynog-SE1369-Ab-1/ GM-Tg-cynog-SE1369-Ab-2; GM-Tg-felg-SE1369-Ab-1/ GM-Tg-felg-SE1369-Ab-2; GM-Tg-cang-SE1369-Ab-1/ GM-Tg-cang-SE1369-Ab-2; GM-Tg-bovg-SE1369-Ab-1/ GM-Tg-bovg-SE1369-Ab-2; GM-Tg-equg-SE1369-Ab-1/ GM-Tg-equg-SE1369-Ab-2  | 
| Products Name | Anti-VWCE monoclonal antibody | 
| Format | mab | 
| Target Name | VWCE | 
| Protein Sub-location | Secreted Protein/Potential Cytokines | 
| Category of antibody | FACS/Biofunctional Antibody | 
| Derivation (species) | Mouse | 
| CH1+2+3 Isotype  (Receptor identification)  | IgG | 
| Type of Light Chain (VD-LC) | N/A | 
| Expression platform | Mammalian Expression | 
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). | 
| Tag | Fc | 
| Products description | Pre-made anti-VWCE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) | 
| Purity | Purity: ≥95% (SDS-PAGE) | 
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. | 
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.  | 
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. | 
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name | 
| Target Antigen | GM-Tg-g-SE1369-Ag-1 | Recombinant multi-species VWCE/ URG11/ VWC1 protein | 
Target information
| Target ID | GM-SE1369 | 
| Target Name | VWCE | 
| Gene ID | 220001,71768,309209,694385,483801,101083799,787487,100059568 | 
| Gene Symbol and Synonyms | 1300015B04Rik,RGD1309910,URG11,VWC1,VWCE | 
| Uniprot Accession | Q96DN2 | 
| Uniprot Entry Name | VWCE_HUMAN | 
| Protein Sub-location | Secreted Protein/Potential Cytokines | 
| Category | |
| Disease | N/A | 
| Gene Ensembl | ENSG00000167992 | 
| Target Classification | N/A | 
The target: VWCE, gene name: VWCE, also named as URG11, VWC1. Predicted to enable calcium ion binding activity. Involved in cellular response to virus. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
                
                
            
        
        
